Marissa Boniszewski
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $439.45 | 21 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $131.14 | 6 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $89.72 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $56.11 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $45.45 | 3 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $44.32 | 2 | $0 (2023) |
| PFIZER INC. | $25.66 | 1 | $0 (2024) |
| Kestra Medical Technology Services, Inc. | $23.98 | 1 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.07 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $93.97 | 4 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($47.74) |
| 2023 | $182.72 | 8 | Janssen Pharmaceuticals, Inc ($88.40) |
| 2022 | $162.76 | 9 | Novartis Pharmaceuticals Corporation ($45.45) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.33 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/20/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $24.41 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/17/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/06/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/10/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.15 | General |
| Category: DIABETES | ||||||
| 06/28/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/21/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/11/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.19 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/01/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/07/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/08/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/03/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/09/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Rare Disease | ||||||
| 08/12/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/17/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/03/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/06/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: RESPIRATORY | ||||||
| 03/11/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.79 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/31/2022 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $23.98 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 295 | 666 | $72,426 | $46,977 |
| 2022 | 5 | 298 | 665 | $66,962 | $41,009 |
| 2021 | 2 | 64 | 183 | $20,189 | $12,449 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 150 | 472 | $44,144 | $28,507 | 64.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 60 | 109 | $15,222 | $10,120 | 66.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 62 | 62 | $8,349 | $5,340 | 64.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 23 | $4,710 | $3,011 | 63.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 143 | 427 | $37,263 | $22,808 | 61.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 67 | 140 | $17,308 | $10,629 | 61.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 60 | 60 | $7,609 | $4,774 | 62.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $3,720 | $2,173 | 58.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 13 | 23 | $1,062 | $624.87 | 58.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 33 | 89 | $11,696 | $7,175 | 61.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 31 | 94 | $8,493 | $5,273 | 62.1% |
About Marissa Boniszewski
Marissa Boniszewski is a Student in an Organized Health Care Education/Training Program healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2018. The National Provider Identifier (NPI) number assigned to this provider is 1780181347.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Marissa Boniszewski has received a total of $439.45 in payments from pharmaceutical and medical device companies, with $93.97 received in 2024. These payments were reported across 21 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($439.45).
As a Medicare-enrolled provider, Boniszewski has provided services to 657 Medicare beneficiaries, totaling 1,514 services with total Medicare billing of $100,435. Data is available for 3 years (2021–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location Williamsville, NY
- Active Since 04/10/2018
- Last Updated 03/26/2025
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1780181347
Products in Payments
- XARELTO (Drug) $131.14
- LifeVest (Device) $89.72
- ENTRESTO (Drug) $45.45
- LOKELMA (Drug) $41.48
- JARDIANCE (Drug) $30.15
- ELIQUIS (Drug) $25.66
- Assure WCD (Device) $23.98
- GATTEX (Drug) $23.07
- ANDEXXA (Biological) $14.63
- STIOLTO RESPIMAT (Drug) $14.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Williamsville
Ryan Denhaese, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $2.7M
James Aitken
Student in an Organized Health Care Education/Training Program — Payments: $35,216
Jack Route, Dpm, DPM
Student in an Organized Health Care Education/Training Program — Payments: $16,044
Dr. Scott Sobieraj, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $4,279
Ndey Diallo, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $4,211
Scott Pollack, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $3,825